IMCD Group (IMCD), a global leader in the distribution and formulation of specialty chemicals and ingredients, will present its latest innovations at CPHI Frankfurt 2025, taking place from 28 to 30 October. The company will unveil a portfolio of greener, smarter, and patient-centric solutions designed to address the evolving needs of the pharmaceutical industry.

At this year’s event, IMCD will demonstrate how its technical expertise, sustainable innovation, and collaborative approach are enabling customers to accelerate development, improve performance, and deliver better outcomes for patients.

IMCD’s exhibition will highlight advanced formulations developed under three key themes: sustainability, intelligence, and patient focus. The company’s “greener” initiatives emphasize eco-friendly excipients and energy-efficient manufacturing processes that reduce environmental impact without compromising product quality. Its “smarter” solutions draw upon IMCD’s global network of technical centres and formulation specialists to tackle complex challenges such as solubility enhancement, modified release, and taste masking. Meanwhile, its “patient-centric” concepts focus on improving compliance, safety, and efficacy through innovative delivery formats that enhance user experience and treatment outcomes.

Chhanda Kapadia, Group Director, Technical Services, IMCD Pharmaceuticals, commented: “Our presence at CPHI reflects IMCD’s commitment to co-creating solutions that are both innovative and sustainable, while keeping patients at the centre of everything we do. These developments are a testament to our globally connected network of technical laboratories and our dedication to shaping the future of healthcare through collaboration and scientific excellence.”